Yıl: 2015 Cilt: 26 Sayı: 3 Sayfa Aralığı: 137 - 144 Metin Dili: Türkçe İndeks Tarihi: 29-07-2022

Positive effect of tadalafil, a phosphodiesterase-5 inhibitor, on fracture healing in rat femur

Öz:
Amaç: Bu çalışmada tadalafilin kırık iyileşmesini sildenafille eşit bir etkinlikte hızlandırıp hızlandırmadığı araştırıldı. Gereç ve yöntemler: Kırık iyileşmesi sıçan kapalı femur kırığı örneği kullanılarak incelendi. Kırk sekiz erkek Wistar albino sıçan (ort. yaş 13 hafta; dağılım 12-14 hafta) üç gruba ayrıldı: 16sına sildenafil (5 mg/kg/gün, oral), 16sına tadalafil (1 mg/kg/gün, oral) ve 16sına (kontrol grubu) her gün serum fizyolojik verildi. İki ve beş hafta sonra her gruptan sekiz sıçana ötanazi yapıldı ve kemik iyileşmesi radyolojik, histolojik ve histomorfometrik analizlerle değerlendirildi. Bulgular: İkinci haftanın sonunda tadalafil grubunun radyolojik skoru sildenafil grubundan yüksek ve her tadanafil hem sidenafil gruplarının skoru kontrol grubundan yüksekken, beşinci haftanın sonunda tüm grupların skorları benzerdi. Sildenafil ve tadalafil uygulanan gruplarda ikinci haftada kallus çapı kontrol grubuna göre daha küçük olarak saptanmış olsa da bu fark istatistiksel olarak anlamlı değildir. Beşinci haftadaki kallus çapı tadalafil grubunda kontrol grubuna göre anlamlı olarak küçüldü. Kontrol grubu ile karşılaştırıldığında, kallusun kıkırdak yüzdesi ikinci haftanın sonunda sildenafil grubunda daha düşük, beşinci haftanın sonunda hem tadalafil hem sildenafil grubunda daha düşüktü. Tadalafil ve sildenafil grupları arasında radyolojik skorlar, kallus çapı, kallusun kıkırdak ve kemik yüzdeleri ve köprüleşme skorları açısından ikinci ve beşinci haftanın sonunda farklılık yoktu. Sonuç: Bu çalışma; tadalafilin sildenafil ile benzer şekilde kemik doku oluşumunu artırarak kırık iyileşmesini hızlandırdığını göstermiştir.
Anahtar Kelime:

Konular: Ortopedi

Bir fosfodiesteraz 5 inhibitörü olan tadalafilin sıçan femurunda kırık iyileşmesi üzerindeki olumlu etkisi

Öz:
Objectives: This study aims to investigate whether tadalafil accelerates fracture healing with an efficiency equal to that of sildenafil. Materials and methods: Fracture healing was studied using a rat closed femur fracture model. Forty-eight male Wistar albino rats (mean age 13 weeks; range 12 to 14 weeks) were divided into three groups: 16 received sildenafil (5 mg/kg/day per oral), 16 received tadalafil (1 mg/kg/day per oral), and 16 (control group) received saline daily. After two and five weeks, eight rats from each group were euthanized and bone healing was evaluated using radiographic, histologic, and histomorphometric analyses. Results: At second week, radiologic score of tadalafil group was higher than the sildenafil treated groups and the sildenafil and tadalafil groups both had higher radiographic scores than the control group, all groups had similar scores at fifth week. The sildenafil and tadalafil treated group exhibited smaller callus diameter at the second week comparing to control group but the difference was not statistically significant, while callus diameter was significantly smaller in tadalafil group when compared to the control group in fifth week. Compared with the control group, cartilage percentage of the callus was lower in the sildenafil group at two weeks and lower in both the tadalafil and sildenafil groups at five weeks. There were no differences between the tadalafil and sildenafil groups regarding the radiographic scores, callus size, cartilage and osseous callus percentage, and the qualitative bridging scores at second or fifth week. Conclusion: This study demonstrated that tadalafil accelerates fracture healing by enhancing osseous tissue formation similar to sildenafil.
Anahtar Kelime:

Konular: Ortopedi
Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Akkaya S, Nazalı M, Kılıç A, Bir F. Cefazolin-sodium has no adverse effect on fracture healing in an experimental rabbit model. Eklem Hastalik Cerrahisi 2012;23:44-8.
  • 2. Halıcı M, Öner M, Güney A, Canöz Ö, Narin F, Halıcı C. Melatonin promotes fracture healing in the rat model. Eklem Hastalik Cerrahisi 2010;21:172-7.
  • 3. Keramaris NC, Calori GM, Nikolaou VS, Schemitsch EH, Giannoudis PV. Fracture vascularity and bone healing: a systematic review of the role of VEGF. Injury 2008;39:45-57.
  • 4. Hankenson KD, Zimmerman G, Marcucio R. Biological perspectives of delayed fracture healing. Injury 2014;45:8-15.
  • 5. Histing T, Garcia P, Matthys R, Leidinger M, Holstein JH, Kristen A, et al. An internal locking plate to study intramembranous bone healing in a mouse femur fracture model. J Orthop Res 2010;28:397-402.
  • 6. Oktaş B, Orhan Z, Erbil B, Değirmenci E, Ustündağ N. Effect of extracorporeal shock wave therapy on fracture healing in rat femural fractures with intact and excised periosteum. Eklem Hastalik Cerrahisi 2014;25:158-62.
  • 7. Chaubey A, Grawe B, Meganck JA, Dyment N, Inzana J, Jiang X, et al. Structural and biomechanical responses of osseous healing: a novel murine nonunion model. J Orthop Traumatol 2013;14:247-57.
  • 8. Lu CY, Chuang HY, Yu FJ, Sun LC, Shih YL, Chen FM, et al. Hypocaloric peripheral parenteral nutrition with lipid emulsion in postoperative gastrointestinal cancer patients. World J Gastrointest Oncol 2010;2:51-5.
  • 9. Lienau J, Schell H, Epari DR, Schütze N, Jakob F, Duda GN, et al. CYR61 (CCN1) protein expression during fracture healing in an ovine tibial model and its relation to the mechanical fixation stability. J Orthop Res 2006;24:254-62.
  • 10. Gur S, Kadowitz PJ, Serefoglu EC, Hellstrom WJ. PDE5 inhibitor treatment options for urologic and non-urologic indications: 2012 update. Curr Pharm Des 2012;18:5590-606.
  • 11. Histing T, Marciniak K, Scheuer C, Garcia P, Holstein JH, Klein M, et al. Sildenafil accelerates fracture healing in mice. J Orthop Res 2011;29:867-73.
  • 12. Yaman F, Atilgan S, Günes N, Agacayak S, Günay A, Ucan MC, et al. Phosphodiesterase-5 inhibitors may facilitate bone defect recovery. Eur Rev Med Pharmacol Sci 2011;15:1301-5.
  • 13. Akgül T, Alemdaroğlu B. Phosphodiesterase 5 inhibitors may facilitate bone fracture recovery. Med Hypotheses 2008;70:461-2.
  • 14. Smith WB, McCaslin IR, Gokce A, Mandava SH, Trost L, Hellstrom WJ. PDE5 inhibitors: considerations for preference and long-term adherence. Int J Clin Pract 2013;67:768-80.
  • 15. Bonnarens F, Einhorn TA. Production of a standard closed fracture in laboratory animal bone. J Orthop Res 1984;2:97-101.
  • 16. Goldberg I, Peylan J, Yosipovitch Z. Late results of excision of the radial head for an isolated closed fracture. J Bone Joint Surg [Am] 1986;68:675-9.
  • 17. Gerstenfeld LC, Wronski TJ, Hollinger JO, Einhorn TA. Application of histomorphometric methods to the study of bone repair. J Bone Miner Res 2005;20:1715-22.
  • 18. Einhorn TA, Gerstenfeld LC. Fracture healing: mechanisms and interventions. Nat Rev Rheumatol 2015;11:45-54.
  • 19. Wright PJ. Comparison of phosphodiesterase type 5 (PDE5) inhibitors. Int J Clin Pract 2006;60:967-75.
  • 20. Kerimoğlu G, Yuluğ E, Kerimoğlu S, Çıtlak A. Effects of leptin on fracture healing in rat tibia. Eklem Hastalik Cerrahisi 2013;24:102-7.
  • 21. Gerber HP, Vu TH, Ryan AM, Kowalski J, Werb Z, Ferrara N. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat Med 1999;5:623-8.
  • 22. Hausman MR, Schaffler MB, Majeska RJ. Prevention of fracture healing in rats by an inhibitor of angiogenesis. Bone 2001;29:560-4.
  • 23. Athanasopoulos AN, Schneider D, Keiper T, Alt V, Pendurthi UR, Liegibel UM, et al. Vascular endothelial growth factor (VEGF)-induced up-regulation of CCN1 in osteoblasts mediates proangiogenic activities in endothelial cells and promotes fracture healing. J Biol Chem 2007;282:26746-53.
  • 24. Pufe T, Wildemann B, Petersen W, Mentlein R, Raschke M, Schmidmaier G. Quantitative measurement of the splice variants 120 and 164 of the angiogenic peptide vascular endothelial growth factor in the time flow of fracture healing: a study in the rat. Cell Tissue Res 2002;309:387-92.
  • 25. Uchida S, Sakai A, Kudo H, Otomo H, Watanuki M, Tanaka M, et al. Vascular endothelial growth factor is expressed along with its receptors during the healing process of bone and bone marrow after drill-hole injury in rats. Bone 2003;32:491-501.
  • 26. Allanore Y. Phosphodiesterase 5 inhibitors in vascular systemic disorders. Joint Bone Spine 2012;79:338-40.
  • 27. Kass DA, Takimoto E, Nagayama T, Champion HC. Phosphodiesterase regulation of nitric oxide signaling. Cardiovasc Res 2007;75:303-14.
  • 28. Corbett SA, Hukkanen M, Batten J, McCarthy ID, Polak JM, Hughes SP. Nitric oxide in fracture repair. Differential localisation, expression and activity of nitric oxide synthases. J Bone Joint Surg [Br] 1999;81:531-7.
  • 29. Carson CC, Lue TF. Phosphodiesterase type 5 inhibitors for erectile dysfunction. BJU Int 2005;96:257-80.
  • 30. Si W, Kang Q, Luu HH, Park JK, Luo Q, Song WX, et al. CCN1/Cyr61 is regulated by the canonical Wnt signal and plays an important role in Wnt3A-induced osteoblast differentiation of mesenchymal stem cells. Mol Cell Biol 2006;26:2955-64.
  • 31. Schütze N, Lechner A, Groll C, Siggelkow H, Hüfner M, Köhrle J, et al. The human analog of murine cystein rich protein 61 [correction of 16] is a 1alpha,25-dihydroxyvitamin D3 responsive immediate early gene in human fetal osteoblasts: regulation by cytokines, growth factors, and serum. Endocrinology 1998;139:1761-70.
  • 32. Crockett JC, Schütze N, Tosh D, Jatzke S, Duthie A, Jakob F, et al. The matricellular protein CYR61 inhibits osteoclastogenesis by a mechanism independent of alphavbeta3 and alphavbeta5. Endocrinology 2007;148:5761-8.
  • 33. Bella AJ, Brock GB. Tadalafil in the treatment of erectile dysfunction. Curr Urol Rep 2003;4:472-8.
  • 34. Uckert S, Stief CG, Jonas U. Current and future trends in the oral pharmacotherapy of male erectile dysfunction. Expert Opin Investig Drugs 2003;12:1521-33.
  • 35. Forgue ST, Phillips DL, Bedding AW, Payne CD, Jewell H, Patterson BE, et al. Effects of gender, age, diabetes mellitus and renal and hepatic impairment on tadalafil pharmacokinetics. Br J Clin Pharmacol 2007;63:24-35.
  • 36. Carter AJ, Ballard SA, Naylor AM. Effect of the selective phosphodiesterase type 5 inhibitor sildenafil on erectile dysfunction in the anesthetized dog. J Urol 1998;160:242-6.
  • 37. Corbin JD, Francis SH. Pharmacology of phosphodiesterase-5 inhibitors. Int J Clin Pract 2002;56:453-9.
APA TOGRAL G, ARIKAN Ş, KORKUSUZ P, HESAR R, EKŞİOĞLU M (2015). Positive effect of tadalafil, a phosphodiesterase-5 inhibitor, on fracture healing in rat femur. , 137 - 144.
Chicago TOGRAL GURAY,ARIKAN Ş. Murat,KORKUSUZ PETEK,HESAR Ramin Hashemi,EKŞİOĞLU M. Fatih Positive effect of tadalafil, a phosphodiesterase-5 inhibitor, on fracture healing in rat femur. (2015): 137 - 144.
MLA TOGRAL GURAY,ARIKAN Ş. Murat,KORKUSUZ PETEK,HESAR Ramin Hashemi,EKŞİOĞLU M. Fatih Positive effect of tadalafil, a phosphodiesterase-5 inhibitor, on fracture healing in rat femur. , 2015, ss.137 - 144.
AMA TOGRAL G,ARIKAN Ş,KORKUSUZ P,HESAR R,EKŞİOĞLU M Positive effect of tadalafil, a phosphodiesterase-5 inhibitor, on fracture healing in rat femur. . 2015; 137 - 144.
Vancouver TOGRAL G,ARIKAN Ş,KORKUSUZ P,HESAR R,EKŞİOĞLU M Positive effect of tadalafil, a phosphodiesterase-5 inhibitor, on fracture healing in rat femur. . 2015; 137 - 144.
IEEE TOGRAL G,ARIKAN Ş,KORKUSUZ P,HESAR R,EKŞİOĞLU M "Positive effect of tadalafil, a phosphodiesterase-5 inhibitor, on fracture healing in rat femur." , ss.137 - 144, 2015.
ISNAD TOGRAL, GURAY vd. "Positive effect of tadalafil, a phosphodiesterase-5 inhibitor, on fracture healing in rat femur". (2015), 137-144.
APA TOGRAL G, ARIKAN Ş, KORKUSUZ P, HESAR R, EKŞİOĞLU M (2015). Positive effect of tadalafil, a phosphodiesterase-5 inhibitor, on fracture healing in rat femur. Eklem Hastalıkları ve Cerrahisi Dergisi (Eski Adı: Artroplasti Artroskopik Cerrahi Derg.), 26(3), 137 - 144.
Chicago TOGRAL GURAY,ARIKAN Ş. Murat,KORKUSUZ PETEK,HESAR Ramin Hashemi,EKŞİOĞLU M. Fatih Positive effect of tadalafil, a phosphodiesterase-5 inhibitor, on fracture healing in rat femur. Eklem Hastalıkları ve Cerrahisi Dergisi (Eski Adı: Artroplasti Artroskopik Cerrahi Derg.) 26, no.3 (2015): 137 - 144.
MLA TOGRAL GURAY,ARIKAN Ş. Murat,KORKUSUZ PETEK,HESAR Ramin Hashemi,EKŞİOĞLU M. Fatih Positive effect of tadalafil, a phosphodiesterase-5 inhibitor, on fracture healing in rat femur. Eklem Hastalıkları ve Cerrahisi Dergisi (Eski Adı: Artroplasti Artroskopik Cerrahi Derg.), vol.26, no.3, 2015, ss.137 - 144.
AMA TOGRAL G,ARIKAN Ş,KORKUSUZ P,HESAR R,EKŞİOĞLU M Positive effect of tadalafil, a phosphodiesterase-5 inhibitor, on fracture healing in rat femur. Eklem Hastalıkları ve Cerrahisi Dergisi (Eski Adı: Artroplasti Artroskopik Cerrahi Derg.). 2015; 26(3): 137 - 144.
Vancouver TOGRAL G,ARIKAN Ş,KORKUSUZ P,HESAR R,EKŞİOĞLU M Positive effect of tadalafil, a phosphodiesterase-5 inhibitor, on fracture healing in rat femur. Eklem Hastalıkları ve Cerrahisi Dergisi (Eski Adı: Artroplasti Artroskopik Cerrahi Derg.). 2015; 26(3): 137 - 144.
IEEE TOGRAL G,ARIKAN Ş,KORKUSUZ P,HESAR R,EKŞİOĞLU M "Positive effect of tadalafil, a phosphodiesterase-5 inhibitor, on fracture healing in rat femur." Eklem Hastalıkları ve Cerrahisi Dergisi (Eski Adı: Artroplasti Artroskopik Cerrahi Derg.), 26, ss.137 - 144, 2015.
ISNAD TOGRAL, GURAY vd. "Positive effect of tadalafil, a phosphodiesterase-5 inhibitor, on fracture healing in rat femur". Eklem Hastalıkları ve Cerrahisi Dergisi (Eski Adı: Artroplasti Artroskopik Cerrahi Derg.) 26/3 (2015), 137-144.